Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

KROMATID Announces Successful Close of $8 Million Series C Funding Round, Exceeding Growth Capital Goals

Summary by KITV4 News
Funding positions KROMATID for accelerated growth in genomic analysis and gene editing technologies

11 Articles

statesmanexaminer.comstatesmanexaminer.com
+9 Reposted by 9 other sources
Center

KROMATID Announces Successful Close of $8 Million Series C Funding Round, Exceeding Growth Capital Goals

Funding positions KROMATID for accelerated growth in genomic analysis and gene editing technologies

·Deer Park, United States
Read Full Article
BizWestBizWest

Genetics firm KromaTid raises $8M Series C – BizWest

Longmont-based gene-analysis company KromaTid Inc. has closed a $8 million Series C round led by investor BroadOak Capital Partners after a recent contribution of an additional $3.8 million.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States on Wednesday, August 20, 2025.
Sources are mostly out of (0)

Similar News Topics

Gene Editing icon

Gene Editing

Utah icon

Utah

News
For You
SearchBlindspotLocal